Antibodies successful in the treatment of the hemolytic-uremic syndrome from EHEC
May 31, 2011 in Diseases, Conditions, SyndromesIn the online version of the New England Journal of Medicine, physicians and scientists in Heidelberg, Montreal, and Paris reported on the successful treatment of three young children who were suffering from a severe hemolytic-uremic syndrome (HUS) after an infection with enterohemorrhagic Escherichia coli (EHEC). The infections occurred in 2010. EHEC are the bacteria that cause the current wave of infections that have already claimed ten lives in Germany. The number of suspected and confirmed cases of EHEC has now reached 700.
Eculizumab has been approved in Germany since 2007 and is used to treat a rare blood disease and a rare congenital form of HUS. Two years ago, American physicians reported similar success in children with this form of HUS (NEJM 2009; 360:544-546).
The children suffered from kidney failure and severe neurological disorders. "After several exchanges of blood plasma had no effect, we decided to attempt treatment with Eculizumab," reports Professor Dr. Franz Schaefer, head of the section of Pediatric Nephrology at the Center for Child and Adolescent Medicine at Heidelberg University Hospital.
Within 24 hours of the initial infusion, which was repeated once or twice at intervals of seven days, the clinical condition of the children improved dramatically. Dialysis due to acute kidney failure from HUS could be discontinued. All three children recovered and had no sequelae even six months after the illness.
The researchers decided on using the monoclonal antibody Eculizumab as it interrupts the destructive immune reactions that occur after an infection with EHEC. Eculizumab binds to protein C5, which activates what is called the complement cascade and lead to the destruction of blood cells among other things. With EHEC infections there can also be complement activation, triggered by the Shiga toxin formed by the bacteria.
"We now hope that these results will help the acutely ill patients," said Professor Schaefer. He assumes that even adult patients can profit from therapy with the antibody. "Because of the epidemic in Germany, the publishers of the New England Journal of Medicine decided to accelerate the publishing date of the article, which they have had since February, and they published it immediately after reviewing it," said Schaefer. In addition, the article was sent to all kidney specialists in Germany.
Meanwhile, first treatments of adults and children in German hospitals have started. The German Society of Nephrologists has issued guidelines that the antibody may be given if all others standard treatments like dialysis and plasmapheresis have failed.
More information: Article in the New England Journal of Medicine: http://www.nejm.or … NEJMc1100859
Provided by
University Hospital Heidelberg
-
German salad warning after food poisoning deaths
May 26, 2011 |
not rated yet |
0
-
Suspected deadly E. coli outbreak in Germany
May 24, 2011 |
not rated yet |
0
-
Germany 'really worried' by E. coli outbreak
May 25, 2011 |
not rated yet |
0
-
Tufts receives patent for antibody treatment against hemolytic uremic syndrome
Feb 28, 2011 |
not rated yet |
0
-
14 dead in Germany as cucumber crisis grows
May 30, 2011 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
7 hours ago |
5 / 5 (1) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Studies examine CPAP treatment and cardiovascular outcomes in adults with obstructive sleep apnea
Two studies that included adults with obstructive sleep apnea examined the effectiveness of reducing the risk of cardiovascular outcomes, including high blood pressure, by treatment with continuous positive airway pressure ...
Diseases, Conditions, Syndromes
10 minutes ago |
not rated yet |
0
Study reveals sarcoidosis-related mortality rates among black women
A new study conducted by researchers from Boston University has found that sarcoidosis accounts for 25 percent of all deaths among women in the Black Women's Health Study who have the disease. The study is the largest epidemiologic ...
Diseases, Conditions, Syndromes
2 hours ago |
not rated yet |
0
Research suggests why bovine TB continues to spread
The failure of the current bovine tuberculosis (TB) eradication programme could be partly due to a parasitic worm that hinders the tests used to diagnose TB in cows, according to new research published this week.
Diseases, Conditions, Syndromes
3 hours ago |
not rated yet |
0
Revised ARDS definition sets out levels of severity
An international task force this week unveiled a revised definition of acute respiratory distress syndrome (ARDS), a disease first recognized during the Vietnam War in casualties with limb injuries who had trouble breathing.
Diseases, Conditions, Syndromes
3 hours ago |
not rated yet |
0
Home damage following Sept. 11 attacks linked with higher levels of respiratory illness
Residents of Lower Manhattan who suffered home damage following the September 11 terrorist attacks are more likely to report respiratory symptoms and diseases than area residents whose homes were not damaged, concludes a ...
Diseases, Conditions, Syndromes
4 hours ago |
not rated yet |
0
Scientists unravel role of fusion gene in prostate cancer
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...
Early-life risk factors for non-Hodgkin lymphoma
Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published May 22 in the Journal of ...
Systems treating severe heart attacks expanding nationwide
The number of systems of care that quickly transfer and treat heart attack patients has increased substantially across the nation, according to research published in Circulation: Cardiovascular Quality and Outcomes, an American ...
Use of multicomponent intervention linked with decrease in using physical restraint in nursing homes
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and ...
Limits to growth: Scientists identify key metastasis-enabling enzyme
(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...
Body building, diet supplements linked to liver damage: study
(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.